Inflammation of the jaws during treatment with bisphosphonates;Kieferentzündungen bei Bisphosphonat-Therapie

Deutsche Medizinische Wochenschrift

Volumn 136, Issue 41, 2011, Pages 2109-2110

  Bartl, R ^a  

^a Osteoporosezentrum München Am Dom ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

DRUG EFFECT; DRUG INFORMATION; DRUG MEGADOSE; HUMAN; JAW OSTEONECROSIS; LETTER; MEDICAL PRACTICE;

ADMINISTRATION, ORAL; AGED; ALENDRONATE; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES, METABOLIC; DIPHOSPHONATES; DRUG APPROVAL; FEMALE; HUMANS; IMIDAZOLES; INFUSIONS, INTRAVENOUS; JAW DISEASES; OPPORTUNISTIC INFECTIONS; OSTEOMYELITIS; OSTEONECROSIS; OSTEOPOROSIS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS;

EID: 80053909818     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0031-1292022     Document Type: Letter

References (16)

1. Arzneimittelkommission der deutschen Ärzteschaft. Osteonekrosen des Kiefers unter Bisphosphonaten. Dtsch Ärzteblatt 2004 101 A2203
2. Arzneimittelkommission der deutschen Ärzteschaft. Bisphosphonate und Knochennekrosen. Dtsch Ärzteblatt 2005 102 B449
3. Bartl R, von Tresckow E, Bartl C. Bisphosphonat-Manual: Wirkungen-Indikationen-Strategien. Heidelberg Springer 2006
4. Bilezikian J. Osteonecrosis of the jaw Do bisphosphonates pose a risk? N Engl J Med 2006 355 2278-2281 (Pubitemid 44837776)
5. Felsenberg D. Kiefernekrosen nach hoch dosierter Bisphosphonattherapie. Dsch Ärzteblatt 2007 46 3078-3080
6. Jeffcoat M. Safety of oral bisphosphonates: Controlled studies on alveolar bone. Int Oral Maxillofac Implants 2006 21 349-353 (Pubitemid 43962658)
7. Kanis J, Burlet N, Cooper C et al,. European guidance for the diagnosis and management of osteoporosis in postmenopausal osteoporosis. Osteoporos Int 2008 19 399-428
8. Marx R. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003 61 1115-1117 (Pubitemid 37064711)
9. Migliorati C. Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 2003 21 4253-4254
10. Pazianas M, Miller P, Blumentals W et al,. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Clinical Therapeutics 2007 29 1548-1557
11. Ruggiero S, Mehrotra B, Rosenberg T, Engroff S. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004 62 527-534 (Pubitemid 38542516)
12. Schwartz H. Osteonecrosis and bisphosphonates: correlation versus causation. J Oral Maxillofac Surg 2004 62 763
13. Shenker N, Jawad A. Bisphosphonates and osteonecrosis of the jaw. Rheumatology 2007 46 1049-1051 (Pubitemid 47050601)
14. Tarassoff P, Csermak K. Avascular necrosis of the jaws: risk factors in metastatic cancer patients. J Oral Maxillofac Surg 2003 61 1238-1239 (Pubitemid 37193509)
15. Woo S, Hellstein J, Kalmar J. Systematic review: Bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 2006 144 753-761 (Pubitemid 46780635)
16. Bartl R. Osteoporose. 4. Aufl. Stuttgart Thieme 2010